On Wednesday, Idera Pharmaceuticals Inc (NASDAQ:IDRA)’s shares inclined 1.11% to $2.74.
Idera Pharmaceuticals, Inc. (IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, declared that it has appointed Mark J. Casey as Senior Vice President, General Counsel and Secretary of the Board of Directors.
Vincent J. Milano, Chief Executive Officer of Idera Pharmaceuticals stated, “Mark’s experience and acumen are perfect matches for Idera and we look forward to the immediate positive impact he will make to our growing team. Importantly, Mark fits incredibly well into the corporate culture we are fostering at Idera that will continue to drive us to delivering therapies for patients suffering from life-threatening diseases whose needs are presently unmet.
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. It uses two proprietary drug discovery technology platforms to design and develop drug candidates, counting toll-like receptor targeting technology and gene silencing oligonucleotide (GSO) technology.
First Horizon National Corp (NYSE:FHN)’s shares dropped -2.32% to $15.55.
First Horizon National Corp. (FHN) will post additional materials for equity analysts in the investor relations section of its website at http://ir.fhnc.com/. First Horizon anticipates to provide these materials to analysts at forthcoming meetings and conferences. The materials will be posted on the website until Sept. 30.
First Horizon National Corporation operates as the bank holding company for First Tennessee Bank National Association that provides various financial services in the United States and internationally. The company offers general banking services for consumers, businesses, financial institutions, and governments. It also provides investments, financial planning, trust, asset administration, credit card, and cash administration services.
At the end of Wednesday’s trade, CBRE Group Inc (NYSE:CBG)‘s shares dipped -2.49% to $37.54.
London’s West End continued to be the world’s highest-priced office market but Asia dominated the world’s most expensive office locations, accounting for four of the top five markets, according to CBRE Group Inc (CBG)’s semi-annual Global Prime Office Occupancy Costs survey.
The study also found that the real estate recovery in the Emerald Isle (Ireland) remained on track, with Dublin (26.1 percent) and Belfast (13.3 percent) showing the largest and fourth-largest year-over-year prime occupancy cost enhances, respectively among the 127 cities surveyed. In North America real estate fundamentals remained strong with Seattle (Downtown), San Francisco (Peninsula) and Vancouver (Suburban) among the 10 markets with the fastest growing prime occupancy costs.
The change in prime office occupancy costs mirrored the gradual recovery of the global economy. Global prime office occupancy costs rose 2.0 percent year-over-year, with the Americas up 2.9 percent, EMEA rising 1.5 percent and Asia Pacific up 1.4 percent.
CBRE tracks occupancy costs for prime office space in 127 markets around the globe. Of the top 50 “most expensive” markets, 19 were in EMEA, 20 were in Asia Pacific and 11 were in the Americas.
CBRE Group, Inc. operates as a commercial real estate services and investment company worldwide. The company operates through Americas; Europe, Middle East and Africa; Asia Pacific; Global Investment Administration; and Development Services segments. It provides advisory services, such as planned advice and execution to owners, investors, and occupiers of real estate in connection with leasing, disposition, and acquisition of property; integrated investment sales and debt/structured financing services under the CBRE Capital Markets brand; and valuation services, counting market value appraisals, litigation support, discounted cash flow analyses, feasibility and fairness opinions, and property condition and environmental consulting, in addition to originates and services commercial mortgage loans.
Tahoe Resources Inc (NYSE:TAHO), ended its Wednesday’s trading session with 8.01% gain, and closed at $9.71.
Tahoe Resources Inc. (TAHO) declare financial results for the quarter ending June 30, 2015 and to provide a production update for operations in Guatemala and Peru.
Highlights for the second quarter of 2015 comprise (all amounts in U.S. dollars unless otherwise stated):
- Silver production from Escobal was 4.5 million ounces (moz) for the quarter, and 9.1 moz for the first half of 2015.
- Gold production from La Arena was 60,282 ounces for the quarter.
- Total revenue of $133.8 million generated from metal sales at operating costs of $114.1 million resulted in mine operating earnings of $19.7 million.
- Net loss for the quarter amounted to $9.3 million or a loss of $0.04 per share. Not taking into account $27.4 million in non-recurring charges incurred as a result of the acquisition of Rio Alto and other adjustments, earnings would be $18.1 million or $0.08 per share.
- Operating cash flow before changes in working capital was $28.0 million or $0.12 per share.
- Sales comprised of 3.8 moz of silver, 61,734 ounces of gold, 1,602 tonnes of lead and 2,507 tonnes of zinc.
Tahoe Resources Inc., together with its auxiliaries, explores for and produces precious metals in the Americas. The company primarily produces silver, in addition to gold, lead, and zinc. Its principal project is the Escobal project located in Southeast Guatemala. The company was formerly known as CKM Resources Inc. and changed its name to Tahoe Resources Inc. in January 2010. Tahoe Resources Inc. was incorporated in 2009 and is headquartered in Reno, Nevada.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
